probenecid has been researched along with Erythema Multiforme in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms.
Excerpt | Relevance | Reference |
---|---|---|
" burgdorferi to survive in the former erythema migrans sites of our antibiotic-treated patients, as well as their favorable clinical response, supports the use of doxycycline or combined amoxicillin and probenecid in the treatment of early Lyme disease but does not preclude the survival of the organism in other tissues." | 3.68 | Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease. ( Berger, BW; Coleman, L; Johnson, RC; Kodner, C, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, BW | 1 |
Johnson, RC | 1 |
Kodner, C | 1 |
Coleman, L | 1 |
1 other study available for probenecid and Erythema Multiforme
Article | Year |
---|---|
Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Borrelia burgdorferi Group; Doxycycline; Erythema M | 1992 |